Trials / Unknown
UnknownNCT02496845
Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
An Open Label Randomized Study to Examine the Safety and Clinical Efficacy of Local Topical Dual Active Preparation for Erectile Dysfunction
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- VasoLead (2012) Ltd. · Academic / Other
- Sex
- Male
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
VL#FIA3-30 is a preparation intended for topical use, applied on the penis, for the treatment of ED.
Detailed description
VasoLead's preparation to treat erectile dysfunction (ED), VL#FIA3-30, is composed of 2 active pharmaceutical ingredients, both act as vasodilators via different mechanisms. Both are currently used orally in the USA and Europe for the treatment of hypertension, angina pectoris and other diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VL#FIA3-30 | Vasoactive dual treatment (MH30-01 \& IS045-01) |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-11-01
- Completion
- 2016-01-01
- First posted
- 2015-07-14
- Last updated
- 2015-07-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02496845. Inclusion in this directory is not an endorsement.